Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Circ Cardiovasc Genet. 2011 Dec 23;5(1):100–112. doi: 10.1161/CIRCGENETICS.111.961292

Table 3.

Literature-reported candidate genes for peripheral artery disease (PAD) and coronary artery disease (CAD) and their association with ankle-brachial index (ABI) in the CHARGE GWAS discovery sample (population isolates excluded) with FDR <0.10.

SNP Chr Physical Position Closest Gene Risk/Non-risk Allele Risk Allele frequency N Beta SE P value* # of effective loci P value corrected False discovery rate
PAD genes
rs10757269 9 22,062,264 CDKN2B G/A 0.51 35036 −0.006 0.001 2.50E-08 69 1.70E-06 9.32E-05
rs3794624 16 87,244,575 CYBA G/A 0.34 31035 −0.005 0.001 6.30E-05 58 3.60E-03 0.0665
rs13290547 9 123,527,316 DAB2IP T/C 0.06 32135 −0.009 0.002 3.60E-05 97 3.50E-03 0.0665
CAD genes
rs4977574 9 22,088,574 CDKN2B G/A 0.49 35411 −0.0047 0.001 2.33E-06 - - 6.52E-05
rs1122608 19 11,024,601 LDLR G/T 0.74 35384 −0.0035 0.001 2.56E-03 - - 0.036
*

P value from Discovery GWAS of ABI

Candidate genes for PAD were selected for testing with ABI if an association study with at least 100 cases and 100 controls was available in the literature independent of whether the study was positive or negative. Genes for CAD were only considered for testing with ABI if they were identified by recent GWAS to be genome-wide significantly associated with CAD. The table shows only the genes which showed an experiment-wise significant association with ABI after correction for multiple testing. The entire list of genes can be seen in Supplementary tables 10 and 11 for PAD and CAD genes, respectively.

Due to the high correlation of imputed genotype scores, the effective number of loci was calculated for each PAD gene region (31) using the genotype scores from the KORA F4 Study. Bonferroni correction of p-values was then applied in each region using this number. Furthermore, the corrected P value thresholds of significance for 28 CAD loci (tested in Suppl Table 11, α=0.05/28, 1.85 x 10−3) and 55 PAD loci (tested in Suppl Table 10, α=0.05/effective number of loci) were calculated. We also calculated a false discovery rate (FDR) using the corrected p-values accounting for the number of gene regions examined. An FDR <0.10 defined evidence of a significant association.